坂根 依利子

Last Update: 2019/06/21 16:00:44

Print

Name(Kanji/Kana/Abecedarium Latinum)
坂根 依利子/サカネ ヨリコ/Sakane, Yoriko
Primary Affiliation(Org1/Job title)
Kyoto University Hospital/Program-Specific Assistant Professor
Academic Degree
Field(Japanese) Field(English) University(Japanese) University(English) Method
博士(医学) 京都大学
Language of Instruction
Language
English
researchmap URL
https://researchmap.jp/7000015444
Published Papers
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
Yamauchi I, Sakane Y, Fukuda Y, Fujii T, Taura D, Hirata M, Hirota K, Ueda Y, Kanai Y, Yamashita Y, Kondo E, Sone M, Yasoda A, Inagaki N Yamauchi I, Sakane Y, Fukuda Y, Fujii T, Taura D, Hirata M, Hirota K, Ueda Y, Kanai Y, Yamashita Y, Kondo E, Sone M, Yasoda A, Inagaki N Yamauchi I, Sakane Y, Fukuda Y, Fujii T, Taura D, Hirata M, Hirota K, Ueda Y, Kanai Y, Yamashita Y, Kondo E, Sone M, Yasoda A, Inagaki N Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study. Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study. Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study. Thyroid : official journal of the American Thyroid Association Thyroid : official journal of the American Thyroid Association Thyroid : official journal of the American Thyroid Association 2017/06 Refereed Disclose to all
Sakane Y, Kanamoto N, Yamauchi I, Tagami T, Morita Y, Miura M, Sone M, Yasoda A, Kimura T, Nakao K, Inagaki N Sakane Y, Kanamoto N, Yamauchi I, Tagami T, Morita Y, Miura M, Sone M, Yasoda A, Kimura T, Nakao K, Inagaki N Sakane Y, Kanamoto N, Yamauchi I, Tagami T, Morita Y, Miura M, Sone M, Yasoda A, Kimura T, Nakao K, Inagaki N Regulation of type 1 iodothyronine deiodinase by LXRα. Regulation of type 1 iodothyronine deiodinase by LXRα. Regulation of type 1 iodothyronine deiodinase by LXRα. PloS one, 12, 6, e0179213 PloS one, 12, 6, e0179213 PloS one, 12, 6, e0179213 2017 Refereed Disclose to all
Ueda Y, Yasoda A, Yamashita Y, Kanai Y, Hirota K, Yamauchi I, Kondo E, Sakane Y, Yamanaka S, Nakao K, Fujii T, Inagaki N Ueda Y, Yasoda A, Yamashita Y, Kanai Y, Hirota K, Yamauchi I, Kondo E, Sakane Y, Yamanaka S, Nakao K, Fujii T, Inagaki N Ueda Y, Yasoda A, Yamashita Y, Kanai Y, Hirota K, Yamauchi I, Kondo E, Sakane Y, Yamanaka S, Nakao K, Fujii T, Inagaki N C-type natriuretic peptide restores impaired skeletal growth in a murine model of glucocorticoid-induced growth retardation. C-type natriuretic peptide restores impaired skeletal growth in a murine model of glucocorticoid-induced growth retardation. C-type natriuretic peptide restores impaired skeletal growth in a murine model of glucocorticoid-induced growth retardation. Bone, 92, 157-167 Bone, 92, 157-167 Bone, 92, 157-167 2016/11 Refereed Disclose to all
Ueda-Sakane Y, Kanamoto N, Fushimi Y, Tanaka-Mizuno S, Yasuno S, Miura M, Sone M, Yasoda A, Okada T, Togashi K, Nakao K, Inagaki N Ueda-Sakane Y, Kanamoto N, Fushimi Y, Tanaka-Mizuno S, Yasuno S, Miura M, Sone M, Yasoda A, Okada T, Togashi K, Nakao K, Inagaki N Ueda-Sakane Y, Kanamoto N, Fushimi Y, Tanaka-Mizuno S, Yasuno S, Miura M, Sone M, Yasoda A, Okada T, Togashi K, Nakao K, Inagaki N Overall safety and efficacy of high-dose and low-dose intravenous glucocorticoid therapy in patients with moderate-to-severe active Graves' ophthalmopathy. Overall safety and efficacy of high-dose and low-dose intravenous glucocorticoid therapy in patients with moderate-to-severe active Graves' ophthalmopathy. Overall safety and efficacy of high-dose and low-dose intravenous glucocorticoid therapy in patients with moderate-to-severe active Graves' ophthalmopathy. Endocrine journal, 63, 8, 703-714 Endocrine journal, 63, 8, 703-714 Endocrine journal, 63, 8, 703-714 2016/08 Refereed Disclose to all
Kondo E, Yasoda A, Fujii T, Nakao K, Yamashita Y, Ueda-Sakane Y, Kanamoto N, Miura M, Arai H, Mukoyama M, Inagaki N, Nakao K Kondo E, Yasoda A, Fujii T, Nakao K, Yamashita Y, Ueda-Sakane Y, Kanamoto N, Miura M, Arai H, Mukoyama M, Inagaki N, Nakao K Kondo E, Yasoda A, Fujii T, Nakao K, Yamashita Y, Ueda-Sakane Y, Kanamoto N, Miura M, Arai H, Mukoyama M, Inagaki N, Nakao K Increased Bone Turnover and Possible Accelerated Fracture Healing in a Murine Model With an Increased Circulating C-Type Natriuretic Peptide. Increased Bone Turnover and Possible Accelerated Fracture Healing in a Murine Model With an Increased Circulating C-Type Natriuretic Peptide. Increased Bone Turnover and Possible Accelerated Fracture Healing in a Murine Model With an Increased Circulating C-Type Natriuretic Peptide. Endocrinology, 156, 7, 2518-2529 Endocrinology, 156, 7, 2518-2529 Endocrinology, 156, 7, 2518-2529 2015/07 Refereed Disclose to all
Kanamoto N, Tagami T, Ueda-Sakane Y, Sone M, Miura M, Yasoda A, Tamura N, Arai H, Nakao K Kanamoto N, Tagami T, Ueda-Sakane Y, Sone M, Miura M, Yasoda A, Tamura N, Arai H, Nakao K Kanamoto N, Tagami T, Ueda-Sakane Y, Sone M, Miura M, Yasoda A, Tamura N, Arai H, Nakao K Forkhead box A1 (FOXA1) and A2 (FOXA2) oppositely regulate human type 1 iodothyronine deiodinase gene in liver. Forkhead box A1 (FOXA1) and A2 (FOXA2) oppositely regulate human type 1 iodothyronine deiodinase gene in liver. Forkhead box A1 (FOXA1) and A2 (FOXA2) oppositely regulate human type 1 iodothyronine deiodinase gene in liver. Endocrinology, 153, 1, 492-500 Endocrinology, 153, 1, 492-500 Endocrinology, 153, 1, 492-500 2012/01 Refereed Disclose to all
Tagami T, Tamanaha T, Shimazu S, Honda K, Nanba K, Nomura H, Yoriko SU, Usui T, Shimatsu A, Naruse M Tagami T, Tamanaha T, Shimazu S, Honda K, Nanba K, Nomura H, Yoriko SU, Usui T, Shimatsu A, Naruse M Tagami T, Tamanaha T, Shimazu S, Honda K, Nanba K, Nomura H, Yoriko SU, Usui T, Shimatsu A, Naruse M Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with Hashimoto thyroiditis. Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with Hashimoto thyroiditis. Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with Hashimoto thyroiditis. Endocrine journal, 57, 3, 253-258 Endocrine journal, 57, 3, 253-258 Endocrine journal, 57, 3, 253-258 2010 Refereed Disclose to all
Title language:
External funds: competitive funds and Grants-in-Aid for Scientific Research (Kakenhi)
Type Position Title(Japanese) Title(English) Period
研究活動スタート支援 Representative 臓器特異的な甲状腺ホルモン脱ヨード酵素の発現調節因子の探索と機序の解明 (平成28年度分) 2016/04/01-2017/03/31
京都大学リサーチ・ディベロップメントプログラム【いしずえ】 Representative 脱ヨード酵素を軸とした新たな甲状腺の疾患概念と治療法の探索 2017/06/15-
研究活動スタート支援 Representative 臓器特異的な甲状腺ホルモン脱ヨード酵素の発現調節因子の探索と機序の解明 (平成29年度分) 2017/04/01-2018/03/31